Press Releases
Media Contact:
Erin Hill
ehill@iivs.org
301-947-1281
IIVS Appointed to China’s Alternatives Working Group for Cosmetics
October 9, 2018Gaithersburg, MD – October 9, 2018 – U.S. based Institute for In Vitro Sciences (IIVS) has been invited by China’s National Institute for Food and Drug Control (NIFDC) to join their working group on alternatives for cosmetics. The newly established group was announced by the NIFDC during their 2nd International ...
IIVS Collaborates with BASF and Givaudan to Validate a Non-animal Test for Regulatory Submissions
August 28, 2018GAITHERSBURG, MD –August 28– The Institute for In Vitro Sciences (IIVS), with an established track record in the validation of alternatives to animal testing, is teaming up with BASF and Givaudan to validate an improved skin sensitization reactivity method to address the needs of ...
IIVS Names Frank Gerberick as Chief Scientific Advisor
March 1, 2018GAITHERSBURG, MD – March 1, 2018 – The Institute for In Vitro Sciences, Inc. (IIVS) announced that it has appointed Frank Gerberick, PhD as its Chief Scientific Advisor. With his expertise and knowledge of technological advances and industry trends, Dr. Gerberick will advise the organization’s governing body on scientific matters and make recommendations on future directions...
IIVS and BASF Collaborate to Distribute Test Method to Replace Animal Testing in China
January 9, 2018GAITHERSBURG, MD – January 9, 2018 – The Institute for In Vitro Sciences, Inc. (IIVS) today announced a collaboration with BASF to import a non-animal, cell based, safety test into China. The LuSens test, developed by BASF, is an in vitro
IIVS Announces the Opening of a Non-animal Testing Laboratory in China
November 14, 2017GAITHERSBURG, MD – Nov. 14, 2017 – The Zhejiang Institute for Food and Drug Control (ZJIFDC), responsible for regulatory review of food, drugs, and cosmetics produced in Zhejiang province, has opened a non-animal testing laboratory after successful scientific collaboration with IIVS. Based near Shanghai, the ZJIFDC made the decision to open the new lab back in 2013 to keep...
IIVS and Colgate-Palmolive Team Up to Provide Training on Non-Animal Methods in Brazil
October 10, 2017GAITHERSBURG, MD – Oct. 10, 2017 – IIVS, supported by a grant from Colgate-Palmolive, held a training course this month in Goiania, Brazil focused on two in vitro methods with international regulatory acceptance status. The course, Alternative Methods for Evaluation of Toxicity, was attended by over 30 participants from industry and government who ...
Chinese FDA and IIVS Re-affirm Their Collaboration for Non-animal Tests
September 7, 2017GAITHERSBURG, MD – Sept. 7, 2017 – Bo Li, General Director of the CFDA’s National Institute for Food and Drug Control (NIFDC) and Erin Hill, President of US based non-profit, Institute for In Vitro Sciences, Inc. (IIVS), signed a Memorandum of Understanding (MOU) to bring non-animal test methods to China for the regulation of cosmetics and ingredients. The move re-affirms ...
Collaborative Effort Aims to Replace Rabbit Test for Personal Lubricant Products
August 21, 2017Study in Response to Consumer Demands for Humane Testing
Washington, D.C. — August 21, 2017 — A first-of-its kind collaborative project is underway to find a non-animal test method to replace the rabbit vaginal irritation test for personal lubricants. The U.S. Food and Drug Administration (FDA) gave the project a green light as part...IIVS Recipient of Device that Mimics Human Exposure to Aerosols
July 10, 2017PETA International Science Consortium Donates VITROCELL® In Vitro Inhalation Exposure System
GAITHERSBURG, MD – July 10, 2017 – The Institute for In Vitro Sciences (IIVS), a leader in non-animal test methods, is the recipient of a VITROCELL® inhalation exposure system thanks to a generous...New In Vitro Respiratory Laboratory, Marking 20 Years of Innovation in Non-Animal Testing
June 13, 2017GAITHERSBURG, MD – June 13, 2017 – The Institute for In Vitro Sciences (IIVS), a leader in non-animal test methods, marked its 20th year with the opening of a new state-of-the-art in vitro respiratory exposure laboratory. The 1,000 square foot facility expands IIVS’ non-animal testing services to include rapid evaluation of potential respiratory hazards associated with novel ...